Literature DB >> 12376176

Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis.

Arielle Crespel1, Philippe Coubes, Marie-Claude Rousset, Corinne Brana, Alain Rougier, Gérard Rondouin, Joël Bockaert, Michel Baldy-Moulinier, Mireille Lerner-Natoli.   

Abstract

Many experimental studies suggest that NFkappaB, a transcription factor involved in acute inflammation, and cytokines participate in neuronal excitability and/or glial scar formation in epilepsy. In this report, we looked for the expression of NFkappaB in hippocampi surgically removed in patients with medial temporal lobe epilepsy (MTLE) and hippocampal sclerosis (HS) who had an history of febrile convulsions. We analyzed 18 hippocampi from epileptic patients with MTLE and HS, and we used as control specimens three hippocampi from non-epileptic patients and four hippocampi from patients with cryptogenic MTLE without HS. We used antibodies raised against the NFkappaB-p65 subunit and we identified glial cells with specific antibodies. Hippocampi from patients with MTLE and HS displayed severe neuronal loss surrounded by gliosis in CA1 area and more or less in CA3/CA4 areas. Double immunolabeling showed that reactive astrocytes of lesioned areas over-expressed NFkappaB-p65 (significantly when compared to control specimens). Moreover, some surviving pyramidal neurons in these areas and numerous dentate granule cells were strongly positive for NFkappaB-p65 in cytoplasm and nucleus, whereas control hippocampi showed a faint basal cytoplasmic staining in neurons. These results suggest that in epileptic hippocampi with typical sclerosis, inflammatory processes are chronically active or transiently re-induced by recurrent seizures. Whether NFkappaB over-expression reflects protective or deleterious mechanisms in the epileptic focus remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376176     DOI: 10.1016/s0006-8993(02)03050-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  81 in total

Review 1.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

2.  Population-level evidence for an autoimmune etiology of epilepsy.

Authors:  Mei-Sing Ong; Isaac S Kohane; Tianxi Cai; Mark P Gorman; Kenneth D Mandl
Journal:  JAMA Neurol       Date:  2014-05       Impact factor: 18.302

3.  Brain Inflammation and Seizures.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2004-03       Impact factor: 7.500

4.  The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5.

Authors:  M S Weinberg; B L Blake; R J Samulski; T J McCown
Journal:  Gene Ther       Date:  2011-04-14       Impact factor: 5.250

5.  Human and rodent temporal lobe epilepsy is characterized by changes in O-GlcNAc homeostasis that can be reversed to dampen epileptiform activity.

Authors:  Richard G Sánchez; R Ryley Parrish; Megan Rich; William M Webb; Roxanne M Lockhart; Kazuhito Nakao; Lara Ianov; Susan C Buckingham; Devin R Broadwater; Alistair Jenkins; Nihal C de Lanerolle; Mark Cunningham; Tore Eid; Kristen Riley; Farah D Lubin
Journal:  Neurobiol Dis       Date:  2019-01-06       Impact factor: 5.996

6.  Leukocyte-endothelial adhesion mechanisms in epilepsy: cheers and jeers.

Authors:  Annamaria Vezzani; Damir Janigro
Journal:  Epilepsy Curr       Date:  2009 Jul-Aug       Impact factor: 7.500

7.  Bilateral hippocampal atrophy in temporal lobe epilepsy: effect of depressive symptoms and febrile seizures.

Authors:  Andrey Finegersh; Christina Avedissian; Sadat Shamim; Irene Dustin; Paul M Thompson; William H Theodore
Journal:  Epilepsia       Date:  2011-01-26       Impact factor: 5.864

8.  Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.

Authors:  Mattia Maroso; Silvia Balosso; Teresa Ravizza; Jaron Liu; Eleonora Aronica; Anand M Iyer; Carlo Rossetti; Monica Molteni; Maura Casalgrandi; Angelo A Manfredi; Marco E Bianchi; Annamaria Vezzani
Journal:  Nat Med       Date:  2010-03-28       Impact factor: 53.440

9.  A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta.

Authors:  Silvia Balosso; Mattia Maroso; Manuel Sanchez-Alavez; Teresa Ravizza; Angelisa Frasca; Tamas Bartfai; Annamaria Vezzani
Journal:  Brain       Date:  2008-10-24       Impact factor: 13.501

Review 10.  Role of brain inflammation in epileptogenesis.

Authors:  Jieun Choi; Sookyong Koh
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.